Skip to main content

Table 1 Sex-specific associations of genetically mimicked statins, PCSK9 inhibitors, and ezetimibe (based on rs12916, rs11591147, and rs10260606, respectively) with continuous phenotypes strongly associated with rs12916 (excluding some body composition traits)

From: A phenome-wide association study of genetically mimicked statins

Trait

Genetically mimicked statins (rs12916)

Genetically mimicked PCSK9 inhibitors (rs11591147)

Genetically mimicked ezetimibe (rs10260606)

Both sexes

Men

Women

P value**

Both sexes

Male

Women

P value**

Both sexes

Male

Women

P value**

Beta*

Pval

Beta*

Pval

Beta*

Pval

Beta*

Pval

Beta*

Pval

Beta*

Pval

Beta*

Pval

Beta*

Pval

Beta*

Pval

ApoB

−0.89

1.02 × 10−112

−0.88

4.03 × 10−38

−0.89

2.49 × 10−79

0.001

−0.99

9.88 × 10−324

−1.01

5.71 × 10−151

−0.97

7.14 × 10−176

0.84

−0.90

5.47 × 10−25

−0.87

1.70 × 10−8

−0.91

4.43 × 10−19

0.06

LDL-c

−1.00

4.32 × 10−144

−1.00

2.45 × 10−49

−1.00

3.25 × 10−100

<0.001

−1.00

0

−1.00

1.18 × 10−150

−1.00

5.02 × 10−189

0.55

−1.00

4.33 × 10−31

−1.00

6.92 × 10−11

−1.00

8.49 × 10−23

0.07

TC

−0.95

9.66 × 10−134

−0.97

1.67 × 10−46

−0.95

1.40 × 10−92

0.002

−0.90

6.07 × 10−278

−0.91

3.18 × 10−124

−0.90

1.19 × 10−157

0.63

−0.90

2.53 × 10−26

−0.91

3.16 × 10−9

−0.91

1.72 × 10−19

0.09

HbA1c

0.19

4.30 × 10−7

0.20

2.65 × 10−03

0.19

3.66 × 10−05

0.61

−0.06

0.013

−0.10

0.011

−0.03

0.329

0.21

0.47

3.12 × 10−8

0.41

0.007

0.51

2.32 × 10−7

0.15

Calcium

−0.22

1.27 × 10−7

−0.15

0.039

−0.26

1.64 × 10−07

0.04

−0.01

0.755

−0.02

0.560

0.003

0.935

0.63

0.08

0.401

0.27

0.090

−0.04

0.705

0.13

SHBG

−0.17

5.68 × 10−6

−0.09

0.189

−0.25

1.15 × 10−06

0.01

0.003

0.893

0.05

0.204

−0.03

0.401

0.14

0.01

0.954

0.06

0.685

−0.05

0.678

0.56

BMR

0.19

5.30 × 10−19

0.26

1.01 × 10−4

0.29

7.01 × 10−10

0.17

−0.01

0.977

−0.03

0.395

0.02

0.637

0.35

−0.02

0.661

0.23

0.120

−0.09

0.367

0.08

MPV

0.21

1.94 × 10−07

0.26

9.97 × 10−5

0.17

5.25 × 10−4

0.62

−0.05

0.068

−0.09

0.022

−0.01

0.746

0.14

−0.44

6.21 × 10−7

−0.71

3.70 × 10−6

−0.26

0.013

0.09

Platelet count

−0.26

7.03 × 10−12

−0.37

3.34 × 10−8

−0.20

1.89 × 10−5

0.26

0.05

0.040

0.07

0.071

0.04

0.267

0.58

0.21

0.014

0.32

0.039

0.16

0.128

0.64

Platelet crit

−0.18

1.27 × 10−6

−0.28

4.30 × 10−5

−0.14

4.17 × 10−3

0.30

0.03

0.152

0.03

0.471

0.04

0.216

0.75

0.01

0.921

−0.04

0.806

0.02

0.865

0.77

BMI

0.32

5.20 × 10−24

0.33

6.11 × 10−7

0.31

3.73 × 10−11

0.41

0.02

0.894

0.03

0.418

−0.02

0.636

0.36

0.05

0.587

0.15

0.317

−0.14

0.178

0.10

Weight

0.27

1.40 × 10−22

0.31

3.07 × 10−6

0.30

1.15 × 10−10

0.33

0.01

0.913

0.03

0.460

−0.03

0.406

0.27

0.01

0.915

0.20

0.198

−0.10

0.321

0.11

HC

0.31

1.30 × 10−21

0.35

1.90 × 10−7

0.28

5.20 × 10−9

0.88

0.02

0.542

0.01

0.768

0.02

0.535

0.84

0.08

0.366

0.09

0.545

−0.15

0.135

0.14

WC

0.24

2.10 × 10−16

0.29

1.71 × 10−5

0.26

2.33 × 10−8

0.52

0.05

0.088

0.01

0.764

0.06

0.067

0.31

0.02

0.773

0.07

0.657

−0.05

0.610

0.50

  1. *Relative effect on LDL-c, i.e., the sex-specific effect size for each trait divided by the absolute value of the corresponding sex-specific effect size for LDL-c
  2. **P value for Z test
  3. HC hip circumference, WC waist circumference